Clinical Trial Update: Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating sintilimab with chemotherapy induction followed by concurrent chemoradiotherapy (CCRT) versus CCRT alone in esophageal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Esophageal Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING